Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Skin microbiota balance refers to the homeostatic state in which the diverse microbial communities (including bacteria, fungi, viruses, and mites) naturally present on the skin exist in equilibrium with each other and the human host. Maintaining this balance is essential for barrier function, immune education, protection against pathogens, and modulation of skin inflammation. Disruption, known as dysbiosis, has been associated with numerous dermatologic conditions, but "skin microbiota balance" itself is not a molecule, gene, or protein and cannot be directly targeted by drugs in the same way as classical therapeutic receptors or enzymes[1][2][3].
Alteration of microbial community composition; Suppression of pathogenic organism overgrowth; Promotion of commensal or beneficial bacteria
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Skin microbiota balance.